Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Task Engagement in Schizophrenia
NCT00440843Phase 3Withdrawn
- Sponsor
- United States Department of Veterans Affairs
- Start
- Feb 2007
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in schizophrenia, schizoaffective disorder, sponsored by United States Department of Veterans Affairs. Planned start Feb 2007; status: withdrawn.
02
Drugs
olanzapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00440843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440843.